IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation
ECONOMY & POLICY

IXP Launches Maiden Rs 2 Bn Fund to Fuel Biotech Innovation

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages.

The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals.

Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”.

Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”.

Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.”

Image Source:https://www.msn.com/

IXP, a Lifesciences VC backed by JV Ventures, has announced the launch of it’s first fund to invest in early-stage companies. The fund aims to build a portfolio of B2B companies ranging from Pre-seed to Series A stages. The IXP Lifesciences Catalyst Fund is targeting a corpus of Rs 2 billion with a greenshoe option of Rs 1 billion. The fund plans to create a portfolio of 20-25 companies addressing gaps in the market for both services and products. Within the Lifesciences sector, the fund will invest across innovation in areas such as pharma, biotechnology, medical technology, speciality chemicals, agrotechnology and nutraceuticals. Ketki Tulpule, Ph.D., CIO at IXP said, “IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to understand the pain points of biotech’s for an outside-in perspective. The sector is nuanced, and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech’s succeed. We are glad to have onboarded industry veterans as council members and advisors who add to the scientific heft of the fund”. Vishal Goel, Partner at IXP and Co-founder of JV Ventures commented, “The Indian Lifesciences industry is dynamic with large untapped potential. Through IXP Venture Studio, we will co-create companies along with scientists for ideas addressing unmet needs in the market. Unlike traditional VCs, IXP has a hands-on approach through active participation from concept to scale. The Ventureprenuer Program has been designed to transform scientists into founders”. Jasmeet Chhabra, Partner at IXP and Co-founder of JV Ventures added, “The success of biotech’s hinges on many factors, not just capital. These early-stage companies require access to larger ecosystems for laboratories, networks and R&D services which we provide through PoweRx, the Lifesciences vertical of JV Ventures. This differentiates IXP from other funds as it leverages synergies within the group to create a winning proposition for portfolio companies.” Image Source:https://www.msn.com/

Next Story
Infrastructure Urban

LogiMAT India 2025 showcases 200+ Cutting-Edge Innovations

LogiMAT India 2025, showcased an impressive array of over 200 innovative products and cutting-edge technologies, set to transform India's thriving logistics sector. Groundbreaking solutions were unveiled at the event by industry pioneers such as Addverb, SICK India, Godrej Körber, Craftsman Automation, Godrej & Boyce, Tata Motors, Anscer Robotics, Armstrong Dematic, KION Group, Nilkamal Ltd., Ferag, Rubber King, Fronius, and many more. The show also spotlighted trailblazing innovations at the Startup Pavilion which was co-curated in partnership with Startup India. LogiMAT India 2025 provide..

Next Story
Infrastructure Urban

ACREX India Opens with a Strong Industry Focus on Sustainability

ACREX India, the premier exhibition spotlighting the latest technological advancements and a comprehensive range of HVAC supply chain innovations, commenced at the Bangalore International Exhibition Centre (BIEC), Bengaluru. Organised by ISHRAE in collaboration with Informa Markets in India, the three-day event serves as a crucial platform for domestic and international manufacturers to engage with government officials, industry leaders, and key stakeholders. This year’s edition is expected to an impressive gathering of over 30,000 visitors and features a diverse showcase by more than 500 ex..

Next Story
Real Estate

Globeop Leases 63,000 Sq Ft in Mumbai

Globeop Financial Services India Private Limited has leased 62,976 sq ft of office space at Nirlon Knowledge Park, Goregaon East, at a monthly rent exceeding Rs 1.05 million for five years. JLL India acted as the transaction advisor for the deal. Lease Details & Rental Terms The financial services firm, a part of SS&C GlobeOp, has taken up the 13th and 14th floors of the building. The lease agreement, signed with Nirlon Ltd, includes a total chargeable area of 62,975.78 sq ft and 63 dedicated parking spaces. The rental structure is set to increase annually: Year 1: Rs 167 per sq ft/month Year..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?